Cargando…
A 24-month retrospective update: follow-up hospitalization charges and readmissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2)
BACKGROUND: The objectives of this study were to build upon previously-reported 12-month findings by retrospectively comparing 24-month follow-up hospitalization charges and potentially-relevant readmissions in US lumbar fusion surgeries that employed either recombinant human bone morphogenetic prot...
Autores principales: | Wetzell, Bradley, McLean, Julie B., Dorsch, Kimberly, Moore, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600873/ https://www.ncbi.nlm.nih.gov/pubmed/34794470 http://dx.doi.org/10.1186/s13018-021-02829-0 |
Ejemplares similares
-
A large database study of hospitalization charges and follow-up re-admissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2)
por: Wetzell, Bradley, et al.
Publicado: (2020) -
Recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in posterolateral lumbar spine fusion: complications in the elderly
por: Hoffmann, Martin F, et al.
Publicado: (2013) -
The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
por: Herford, A.S.
Publicado: (2017) -
Efficacy of rhBMP-2 and Allograft Cellular Bone Matrix in the Revision of Alveolar Bone Grafting
por: Harrison, Lucas, et al.
Publicado: (2023) -
Safety and Efficacy of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) in Craniofacial Surgery
por: Ramly, Elie P., et al.
Publicado: (2019)